EUVIMEDEUVIMED entdecken
Crossref

TAilored SToma policY after TME for rectal cancer: The TASTY approach

Lara Boissieras, Deena Harji iD, Bertrand Celerier, Eric Rullier, Quentin Denost iD

Colorectal Disease · 2024

DOI: 10.1111/codi.17095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, 2024. Verfasst von Lara Boissieras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery, CHU Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Rectal Neoplasms, Anastomotic Leak, Surgical Stomas. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Diverting stomas are routinely used in restorative surgery following total mesorectal exicision (TME) for rectal cancer to mitigate the clinical risks of anastomotic leakage (AL). However, routine diverting stomas are associated with their own complication profile and may not be required in all patients. A tailored approach based on personalized risk of AL and selective use of diverting stoma may be more appropriate. The aim of the TAilored SToma policY (TASTY) project was to design and pilot a standardized, tailored approach to diverting stoma in low rectal cancer.

Method

A mixed‐methods approach was employed. Phase I externally validated the anastomotic failure observed risk score (AFORS). We compared the observed rate of AL in our cohort to the theoretical, predicted risk of the AFORS score. To identify the subset of patients who would benefit from early closure of the diverting stoma using C‐reactive protein (CRP) we calculated the Youden index. Phase II designed the TASTY approach based on the results of Phase I. This was evaluated within a second prospective cohort study in patients undergoing TME for rectal cancer between April 2018 and April 2020.

Results

A total of 80 patients undergoing TME surgery for rectal cancer between 2016 and 2018 participated in the external validation of the AFORS score. The overall observed AL rate in this cohort of patients was 17.5% ( n = 14). There was a positive correlation between the predicted and observed rates of AL using the AFORS score. Using ROC curves, we calculated a CRP cutoff value of 115 mg/L on postoperative day 2 for AL with a sensitivity of 86% and a negative predictive value of 96%. The TASTY approach was designed to allocate patients with a low risk AFORS score to primary anastomosis with no diverting stoma and high risk AFORS score patients to a diverting stoma, with early closure at 8–14 days, if CRP values and postoperative CT were satisfactory. The TASTY approach was piloted in 122 patients, 48 (39%) were identified as low risk (AFORS score 0–1) and 74 (61%) were considered as high risk (AFORS score 2–6). The AL rate was 10% in the low‐risk cohort of patient compared to 23% in the high‐risk cohort of patients, p = 0.078 The grade of Clavien‐Dindo morbidity was equivalent. The incidence of major LARS was lowest in the no stoma cohort at 3 months ( p = 0.014).

Conclusion

This study demonstrates the feasibility and safety of employing a selective approach to diverting stoma in patients with a low anastomosis following TME surgery for rectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsAnastomotic LeakSurgical StomasHumansMaleFemaleMiddle AgedAgedProspective StudiesRisk AssessmentPilot ProjectsC-Reactive ProteinAdult

Stichwörter der Autor:innen

Rectal canceranastomotic leakdefunctionning stomafunctional outcomesquality of life

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Colorectal Surgery, CHU Bordeaux, Bordeaux, France.
  • Bordeaux Colorectal Institute, Bordeaux, France.

ORCID-Profile: Deena Harji, Quentin Denost

Zitieren

APA

Boissieras, L., Harji, D., Celerier, B., Rullier, E., & Denost, Q. (2024). TAilored SToma policY after TME for rectal cancer: The TASTY approach. Colorectal Disease. https://doi.org/10.1111/codi.17095

Vancouver

Boissieras L, Harji D, Celerier B, Rullier E, Denost Q. TAilored SToma policY after TME for rectal cancer: The TASTY approach. Colorectal Disease. 2024. doi:10.1111/codi.17095

BibTeX
@article{Boissieras2024,
  author = {Boissieras, Lara and Harji, Deena and Celerier, Bertrand and Rullier, Eric and Denost, Quentin},
  title = {TAilored SToma policY after TME for rectal cancer: The TASTY approach},
  journal = {Colorectal Disease},
  year = {2024},
  doi = {10.1111/codi.17095}
}
Kostenlos starten →